CCL5 and ovarian carcinoma: Higher concentrations of CCL5 are also observed in patients with residual tumor mass than without it, confirming that CCL5 plays a role in ovarian carcinoma progression and suggesting that serum CCL5 levels are a potential diagnostic and prognostic marker [180].